Boggs Jennifer M, Beck Arne, Ritzwoller Debra P, Battaglia Catherine, Anderson Heather D, Lindrooth Richard C
Kaiser Permanente Colorado Institute for Health Research, 2550 S. Parker Rd., Suite 200, Aurora, CO, 80014, USA.
University of Colorado Anschutz Medical Campus, Aurora, USA.
J Gen Intern Med. 2020 Jun;35(6):1709-1714. doi: 10.1007/s11606-020-05641-4. Epub 2020 Feb 10.
Counseling on access to lethal means is highly recommended for patients with suicide risk, but there are no formal evaluations of its impact in real-world settings.
Evaluate whether lethal means assessment reduces the likelihood of suicide attempt and death outcomes.
Quasi-experimental design using an instrumental variable to overcome confounding due to unmeasured patient characteristics that could influence provider decisions to deliver lethal means assessment.
Kaiser Permanente Colorado, an integrated health system serving over 600,000 members, with comprehensive capture of all electronic health records, medical claims, and death information.
Adult patients who endorsed suicide ideation on the Patient Health Questionnaire-9 (PHQ-9) depression screener administered in behavioral health and primary care settings from 2010 to 2016.
Provider documentation of lethal means assessment in the text of clinical notes, collected using a validated Natural Language Processing program.
Main outcome was ICD-9 or ICD-10 codes for self-inflicted injury or suicide death within 180 days of index PHQ-9 event.
We found 33% of patients with suicide ideation reported on the PHQ-9 received lethal means assessment in the 30 days following identification. Lethal means assessment reduced the risk of a suicide attempt or death within 180 days from 3.3 to 0.83% (p = .034, 95% CI = .069-.9).
Unmeasured suicide prevention practices that co-occur with lethal means assessment may contribute to the effects observed.
Clinicians should expand the use of counseling on access to lethal means, along with co-occurring suicide prevention practices, to all patients who report suicide ideation.
对于有自杀风险的患者,强烈建议进行关于获取致命手段的咨询,但尚无对其在现实环境中影响的正式评估。
评估致命手段评估是否能降低自杀未遂和死亡结果的可能性。
采用工具变量的准实验设计,以克服因未测量的患者特征可能影响提供者进行致命手段评估决策而产生的混杂因素。
科罗拉多州凯撒医疗集团,这是一个为超过60万会员服务的综合医疗系统,全面收集所有电子健康记录、医疗理赔和死亡信息。
2010年至2016年在行为健康和初级保健环境中接受患者健康问卷-9(PHQ-9)抑郁筛查时认可自杀意念的成年患者。
使用经过验证的自然语言处理程序收集临床记录文本中提供者对致命手段评估的记录。
主要结局是索引PHQ-9事件后180天内自我伤害或自杀死亡的ICD-9或ICD-10编码。
我们发现,在PHQ-9上报告有自杀意念的患者中,33%在被识别后的30天内接受了致命手段评估。致命手段评估将180天内自杀未遂或死亡的风险从3.3%降至0.83%(p = 0.034,95%CI = 0.069 - 0.9)。
与致命手段评估同时出现的未测量的自杀预防措施可能导致观察到的效果。
临床医生应将关于获取致命手段的咨询以及同时进行的自杀预防措施扩大到所有报告有自杀意念的患者。